Insider Stock Trading History of Levy Richard N


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Levy Richard N since year 2005. The trader's CIK number is 1413810. At the time of this reporting, Levy Richard N is the Other of Unigene Laboratories Inc . (stock ticker symbol UGNE). See this page for all insider trading activities at Unigene Laboratories Inc .

Note that in the past Levy Richard N also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Levy Richard N since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2010-12-20 UGNE Unigene Laboratories Inc Buy 50,000 .75 37,500
2010-12-21 UGNE Unigene Laboratories Inc Buy 50,000 .75 37,500
2010-12-22 UGNE Unigene Laboratories Inc Buy 50,000 .74 37,000
2010-12-15 UGNE Unigene Laboratories Inc Buy 75,000 .69 51,749
2010-12-17 UGNE Unigene Laboratories Inc Buy 26,100 .72 18,792
2010-09-03 UGNE Unigene Laboratories Inc Buy 5,000 .72 3,600
2010-08-30 UGNE Unigene Laboratories Inc Buy 18,917 .68 12,863
2010-08-31 UGNE Unigene Laboratories Inc Buy 50,000 .70 35,000
2010-08-27 UGNE Unigene Laboratories Inc Buy 176,633 .65 114,811
2009-07-31 GEYH Global Employment Holdings, Inc. Buy 506,061 .02 10,121
2009-06-30 PCQC Pantheon China Acquisition Corp. Sale 2,273,700 5.99 13,619,463
2008-11-26 GLOB Global Med Technologies Inc Buy 29,500 .88 26,107
2008-11-20 GLOB Global Med Technologies Inc Buy 299,925 .58 173,956
2008-10-10 GLOB Global Med Technologies Inc Buy 441,000 .82 363,825
2008-09-30 GLOB Global Med Technologies Inc Buy 145,000 1.30 189,225

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Levy Richard N (Other of Unigene Laboratories Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.